Dishman Carbogen Amcis Ltd - 540701 - SUBMISSION OF CERTIFICATE FOR THE YEAR ENDED ON 31ST MARCH, 2023 AS REQUIRED UNDER REGULATION 40 (9) OF SEBI (LODR) REGULATIONS, 2015
We submit herewith the Certificate for the year ended on 31st March, 2023, as certified and issued by the practicing company secretary. Dishman Carbogen Amcis Ltd - 540701 - SUBMISSION OF COMPLIANCE CERTIFICATE PURSUANT TO REGULATION 7 (3) OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015
As per the provisions of Regulation 7 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Compliance Certificate for the year ended on 31st March, 2023, as certified and signed by the Compliance Officer of the Company and the authorized representative of the Company''s Registrar and Share Transfer Agent viz., Link Intime India Private Limited. Dishman Carbogen Amcis Ltd - 540701 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We submit herewith the confirmation certificate received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) as per regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2023. Dishman Carbogen Amcis Ltd - 540701 - Closure of Trading Window
We would like to inform that as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the Trading Window for dealing in securities/ shares of the Company shall remain closed with effect from 1st April, 2023 for all the Directors, Designated Persons and their immediate relative(s). The Trading Window will be opened 48 hours after the announcement of the Audited Financial Results of the Company for the quarter and year ended 31st March, 2023. Dishman Carbogen Amcis Ltd - 540701 - Board Meeting Outcome for BOARD APPROVES ISSUE OF SENIOR, RATED, LISTED, SECURED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES AGGREGATING UP TO RS. 100 CRORES
We would like to inform you that the Board of Directors of the Company has at its meeting held today, i.e., Friday, March 10, 2023 which was commenced at 03:00 p.m. and concluded at 04:45 p.m., approved issuance of up to 10,000 (Ten thousand) senior, rated, listed, secured, redeemable, non-convertible debentures of face value of Rs. 1,00,000/- (Rupees One Lac only) each, aggregating up to Rs. 100,00,00,000/- (Rupees One Hundred Crores), on a private placement basis (the 'Issue' or 'Debentures' or 'NCDs'). The Disclosures with respect to the Debentures pursuant to SEBI circular bearing reference number: CIR/CFD/CMD/4/2015 dated September 9, 2015 read with Regulation 30 of the SEBI LODR Regulations is attached as Annexure - I with the file AND detailed disclosure also mentioned in the file. Dishman Carbogen Amcis Ltd - 540701 - Board Meeting Intimation for Consideration And Approval Of The Proposal Of Fund Raising By Way Of Issuance Of Non-Convertible Debentures, By Way Of Private Placement, Subject To Such Regulatory Or Statutory Approvals As May Be Required
Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/03/2023 ,inter alia, to consider and approve the proposal of fund raising by way of issuance of Non-Convertible Debentures, by way of private placement, subject to such regulatory or statutory approvals as may be required
This beaten down pharma stock has zoomed over 50% in last 11 trading days
Shares of Dishman Carbogen Amcis zoomed 14 per cent to Rs 124 on the BSE in Tuesday's intra-day trade on the back of heavy volumes Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform that the details of schedule of Analyst/ Investor Meeting with the Company is mentioned in the attached letter. Dishman Carbogen Amcis Ltd - 540701 - Disclosure Pursuant To Regulation 30 Of SEBI (LODR) Regulations, 2015: The Company'S Wholly Owned Subsidiary, CARBOGEN AMCIS AG Successfully Completed US FDA Inspection Of Its Headquarters Site In Bubendorf, Switzerland
We would like to inform that the Company's wholly owned subsidiary, CARBOGEN AMCIS AG's manufacturing site in Bubendorf, Switzerland, has successfully completed a routine U.S. Food and Drug Administration (FDA) inspection. The inspection was concluded without any major or critical observations. Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, pls. find enclosed herewith transcript of earnings conference call arranged by the Company with Investors on Friday, 10th February, 2023 to discuss the financial result and performance of the Company for the quarter ended on 31st December, 2022. The aforesaid transcript is also being hosted on the website of the Company, www.imdcal.com in accordance with the Regulation 46 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.